Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

New metal complexes as potential therapeutics.

Christiana Xin Zhang¹, Stephen J Lippard

¹Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 01239, USA.

Current Opinion in Chemical Biology

|August 28, 2003

Summary

Metal-based drugs, like cisplatin, offer cancer treatment options but face challenges. New metal complexes and delivery systems are being developed to improve efficacy and reduce side effects in cancer therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Leveraging platinum-protein interactions to overcome chemoresistance.

Nature communications·2025

Same author

Mobile zinc as a modulator of sensory perception.

FEBS letters·2022

Same author

Aneuploidy increases resistance to chemotherapeutics by antagonizing cell division.

Proceedings of the National Academy of Sciences of the United States of America·2020

Same author

Enhancing chemotherapy response through augmented synthetic lethality by co-targeting nucleotide excision repair and cell-cycle checkpoints.

Nature communications·2020

Same author

A Platinum(IV) Prodrug-Perfluoroaryl Macrocyclic Peptide Conjugate Enhances Platinum Uptake in the Brain.

Journal of medicinal chemistry·2020

Same author

Native Zinc Catalyzes Selective and Traceless Release of Small Molecules in β-Cells.

Journal of the American Chemical Society·2020

Area of Science:

Medicinal Chemistry
Oncology
Biotechnology

Background:

Metal ions play crucial roles in biological systems, driving the development of metal-based therapeutics.
Cisplatin is a key metal-based drug for cancer treatment, particularly effective against genitourinary tumors.
Limitations of cisplatin include significant side effects and the development of drug resistance.

Purpose of the Study:

To explore novel metal-based compounds and strategies for improved cancer chemotherapy.
To investigate the potential of modified platinum complexes, ruthenium, and gold complexes in cancer treatment.
To examine metal-based compounds that modulate biological properties of reactive oxygen species.

Main Methods:

Development and synthesis of novel metal complexes (platinum, ruthenium, gold).
Conjugation of metal complexes to biological carriers for targeted delivery.
Investigation of DNA binding modes of novel platinum complexes.
Evaluation of metal-based superoxide dismutase mimics and nitric oxide donors/scavengers.

Main Results:

Biological carriers enhance specificity for tumor tissues, reducing side effects and drug resistance.
Platinum complexes with alternative DNA binding modes show promising anti-cancer properties.
Ruthenium and gold complexes demonstrate antitumor activity.
Metal-based compounds targeting superoxide anion and nitric oxide show potential therapeutic applications.

Conclusions:

Metal-based therapeutics offer a promising avenue for cancer treatment, with ongoing advancements in drug design and delivery.
Novel metal complexes and strategies are crucial for overcoming limitations of existing therapies like cisplatin.
Targeting reactive oxygen species with metal-based compounds presents a new frontier in chemotherapy.

Related Experiment Videos